Literature DB >> 19592492

Increased cytokine production in interleukin-18 receptor alpha-deficient cells is associated with dysregulation of suppressors of cytokine signaling.

Claudia A Nold-Petry1, Marcel F Nold, Jason W Nielsen, Alex Bustamante, Jarod A Zepp, Kathleen A Storm, Jae-Woo Hong, Soo-Hyun Kim, Charles A Dinarello.   

Abstract

Since interleukin (IL)-18 is a proinflammatory cytokine, mice lacking IL-18 or its ligand-binding receptor (IL-18R) should exhibit decreased cytokine and chemokine production. Indeed, production of IL-1alpha, IL-6, and MIP-1alpha was reduced in IL-18 knock-out (ko) mouse embryonic fibroblast (MEF)-like cells. Unexpectedly, we observed a paradoxical 10-fold increase in IL-1beta-induced IL-6 production in MEF cells from mice deficient in the IL-18R alpha-chain (IL-18Ralpha) compared with wild type MEF. Similar increases were observed for IL-1alpha, MIP-1alpha, and prostaglandin E2. Likewise, coincubation with a specific IL-18Ralpha-blocking antibody augmented IL-1beta-induced cytokines in wild type and IL-18 ko MEF. Stable lines of IL-18Ralpha-depleted human A549 cells were generated using shRNA, resulting in an increase of IL-1beta-induced IL-1alpha, IL-6, and IL-8 compared to scrambled small hairpin RNA. In addition, we silenced IL-18Ralpha with small interfering RNA in primary human blood cells and observed up to 4-fold increases in the secretion of lipopolysaccharide- and IL-12/IL-18-induced IL-1beta, IL-6, interferon-gamma, and CD40L. Mechanistically, despite increases in Stat1 and IL-6, induction of SOCS1 and -3 (suppressor of cytokine signaling 1 and 3) was markedly reduced in the absence of IL-18Ralpha. Consistent with these observations, activation of the p38alpha/beta and ERK1/2 MAPKs and of protein kinase B/Akt increased in IL-18Ralpha ko MEF, whereas the negative feedback kinase MSK2 was more active in IL-18 ko cells. These data reveal a role for SOCS1 and -3 in the seemingly paradoxical hyperresponsive state in cells deficient in IL-18Ralpha, supporting the concept that IL-18Ralpha participates in both pro- and anti-inflammatory responses and that an endogenous ligand engages IL-18Ralpha to deliver an inhibitory signal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592492      PMCID: PMC2757991          DOI: 10.1074/jbc.M109.004184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor.

Authors:  K Hoshino; H Tsutsui; T Kawai; K Takeda; K Nakanishi; Y Takeda; S Akira
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

2.  Interleukin-18 receptor signaling is not required for autoantibody production and end-organ disease in murine lupus.

Authors:  Ling Lin; Stanford L Peng
Journal:  Arthritis Rheum       Date:  2005-03

3.  Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR.

Authors:  Kevin McLoughlin; Ken Turteltaub; Danute Bankaitis-Davis; Richard Gerren; Lisa Siconolfi; Kathleen Storm; John Cheronis; David Trollinger; Dennis Macejak; Victor Tryon; Michael Bevilacqua
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

4.  Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation.

Authors:  Ashley Mansell; Rosealee Smith; Sarah L Doyle; Pearl Gray; Jennifer E Fenner; Peter J Crack; Sandra E Nicholson; Douglas J Hilton; Luke A J O'Neill; Paul J Hertzog
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

5.  Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance.

Authors:  Mihai G Netea; Leo A B Joosten; Eli Lewis; Dalan R Jensen; Peter J Voshol; Bart Jan Kullberg; Cees J Tack; Han van Krieken; Soo-Hyun Kim; Anton F Stalenhoef; Fons A van de Loo; Ineke Verschueren; Leslie Pulawa; Shizuo Akira; Robert H Eckel; Charles A Dinarello; Wim van den Berg; Jos W M van der Meer
Journal:  Nat Med       Date:  2006-05-28       Impact factor: 53.440

6.  Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation.

Authors:  Alexandra Zanin-Zhorov; Guy Tal; Shoham Shivtiel; Michal Cohen; Tsvee Lapidot; Gabriel Nussbaum; Raanan Margalit; Irun R Cohen; Ofer Lider
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation.

Authors:  Ilona Gutcher; Eduard Urich; Karina Wolter; Marco Prinz; Burkhard Becher
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

8.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome.

Authors:  Karin Mazodier; Valérie Marin; Daniela Novick; Catherine Farnarier; Stéphane Robitail; Nicolas Schleinitz; Véronique Veit; Pascale Paul; Menachem Rubinstein; Charles A Dinarello; Jean-Robert Harlé; Gilles Kaplanski
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

9.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response.

Authors:  D Novick; S H Kim; G Fantuzzi; L L Reznikov; C A Dinarello; M Rubinstein
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

10.  Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.

Authors:  Helle Frobøse; Sif Groth Rønn; Peter E Heding; Heidi Mendoza; Philip Cohen; Thomas Mandrup-Poulsen; Nils Billestrup
Journal:  Mol Endocrinol       Date:  2006-03-16
View more
  21 in total

Review 1.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 2.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Authors:  Elizabeth D Mellins; Claudia Macaubas; Alexei A Grom
Journal:  Nat Rev Rheumatol       Date:  2011-06-07       Impact factor: 20.543

3.  IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation.

Authors:  Mohammad Hasan Zaki; Peter Vogel; Mathilde Body-Malapel; Mohamed Lamkanfi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2010-09-20       Impact factor: 5.422

4.  Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.

Authors:  Suzhao Li; C Preston Neff; Kristina Barber; Jaewoo Hong; Yuchun Luo; Tania Azam; Brent E Palmer; Mayumi Fujita; Cecilia Garlanda; Alberto Mantovani; Soohyun Kim; Charles Anthony Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-05       Impact factor: 11.205

5.  The pathological role of IL-18Rα in renal ischemia/reperfusion injury.

Authors:  Tomohiro Yano; Yuji Nozaki; Koji Kinoshita; Shoichi Hino; Yasuaki Hirooka; Kaoru Niki; Hideki Shimazu; Kazuya Kishimoto; Masanori Funauch; Itaru Matsumura
Journal:  Lab Invest       Date:  2014-10-20       Impact factor: 5.662

6.  Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt.

Authors:  Chun-Jie Gao; Pei-Jun Ding; Li-Li Yang; Xu-Feng He; Meng-Jiao Chen; Dong-Ming Wang; Yan-Xin Tian; Hui-Min Zhang
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 7.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

Review 8.  IL-18 in inflammatory and autoimmune disease.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Mikael C I Karlsson
Journal:  Cell Mol Life Sci       Date:  2013-07-27       Impact factor: 9.261

9.  Role of IL-18 in second-hand smoke-induced emphysema.

Authors:  Adelheid Kratzer; Jonas Salys; Claudia Nold-Petry; Carlyne Cool; Martin Zamora; Russ Bowler; Andreas Rembert Koczulla; Sabina Janciauskiene; Michael G Edwards; Charles A Dinarello; Laimute Taraseviciene-Stewart
Journal:  Am J Respir Cell Mol Biol       Date:  2013-06       Impact factor: 6.914

10.  Interleukin-18 mediates interleukin-1-induced cardiac dysfunction.

Authors:  Stefano Toldo; Eleonora Mezzaroma; Laura O'Brien; Carlo Marchetti; Ignacio M Seropian; Norbert F Voelkel; Benjamin W Van Tassell; Charles A Dinarello; Antonio Abbate
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.